Skip to main content
. 2016 Mar 7;22(9):2844–2854. doi: 10.3748/wjg.v22.i9.2844

Figure 1.

Figure 1

Cumulative incidence of hepatic decompensation and/or serious adverse events using the Kaplan-Meier method. The dashed line indicates the time at which 24-wk and 48-wk treatment regimens were completed. The dotted line indicates the 4-wk post end of treatment surveillance period.